EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Enhanced growth and sodium-proton antiport activity response to serum in cultured fibroblasts of diabetic patients with nephropathy



Enhanced growth and sodium-proton antiport activity response to serum in cultured fibroblasts of diabetic patients with nephropathy



Acta Diabetologica 29(3-4): 178-181




(PDF emailed within 1 workday: $29.90)

Accession: 031250103

Download citation: RISBibTeXText



Related references

Overactivity of sodium proton antiport and enhanced cell growth in fibroblasts of type 1 insulin dependent diabetic patients with nephropathy. Diabetologia 32(7): 549A, 1989

Sodium proton antiport activity and cell growth in cultured skin fibroblasts of iddm patients with nephropathy. Diabetes 41(10): 1239-1246, 1992

Proliferation and sodium-proton antiport activity in human fibroblasts from type I diabetic patients with nephropathy. American Journal of Hypertension 6(2): 170-173, 1993

Overactivity of sodium proton antiport and enhanced cell growth in fibroblasts of type 1 insulin dependent diabetics with nephropathy. Kidney International 37(1): 199, 1990

Leukocyte sodium proton antiport activity in type 1 insulin dependent diabetic patients with nephropathy. Diabetologia 33(6): 371-377, 1990

Platelet sodium proton antiport activity in patients with insulin dependent diabetes mellitus with and without diabetic nephropathy. Journal of the American Society of Nephrology 2(3): 288, 1991

Na+/H+ antiport activity and cell growth in cultured skin fibroblasts of IDDM patients with nephropathy. Diabetes 41(10): 1239-1246, 1992

Lipids and cellular sodium proton antiport activity in diabetic nephropathy. Kidney International 41(4): 872-876, 1992

Enhanced proliferation in cultured skin fibroblasts from patients with type I diabetes and nephropathy Role of sodium-proton antiporter. Journal Of The American Society Of Nephrology. 3(3): 761, 1992

Intracellular pH and sodium, proton antiport activity of cultured skin fibroblasts from diabetics. Kidney International 42(5): 1184-1190, 1992

Proliferation and Na+/H+ antiport activity in human fibroblasts from type I diabetic patients with nephropathy. American Journal of Hypertension 6(2): 170-173, 1993

Aberrant behaviour of cultured skin fibroblasts from type 1 diabetic patients with nephropathy in response to serum induced cell cycle entry. Journal of the American Society of Nephrology 10(PROGRAM AND ABSTR ISSUE): 489A, Sept, 1999

Cytotoxic t lymphocyte ctl mediated cytolysis proceeds in the absence of sodium proton antiport activity regulation of cytosolic ph by the sodium proton antiport in a cloned ctl. Cellular Immunology 135(1): 208-221, 1991

Blockade of the sodium proton antiport abolishes growth factor induced dna synthesis in fibroblasts structure activity relationships in the amiloride series. Journal of Biological Chemistry 259(7): 4313-4319, 1984

The amiloride sensitive sodium proton antiport in 3t3 fibroblasts characterization and stimulation by serum. Journal of Biological Chemistry 258(10): 6272-6276, 1983